These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 12244914

  • 1. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE, Fourcade L, Pradines B, Hovette P, Paule P, Heno P.
    Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
    [Abstract] [Full Text] [Related]

  • 2. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD, Kotecka BM, Anderson KL, Pombo DJ, Kyle DE, Rieckmann KH, Good MF.
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [Abstract] [Full Text] [Related]

  • 5. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D, Dutoit E, Masson V, Inglebert P, Delhaes L.
    Med Trop (Mars); 2002 Oct; 62(3):225-8. PubMed ID: 12244915
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Atovaquone/proguanil resistance in Africa: a case report.
    David KP, Alifrangis M, Salanti A, Vestergaard LS, Rønn A, Bygbjerg IB.
    Scand J Infect Dis; 2003 Oct; 35(11-12):897-8. PubMed ID: 14723376
    [Abstract] [Full Text] [Related]

  • 8. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
    Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
    [Abstract] [Full Text] [Related]

  • 9. [Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
    Malvy D, Djossou F, Vatan R, Pistone T, Etienne G, Longy-Boursier M, Le Bras M.
    Med Trop (Mars); 2002 Apr; 62(3):229-31. PubMed ID: 12244916
    [Abstract] [Full Text] [Related]

  • 10. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L, Pradines B, Parzy D, Durand R, Bigot P, Le Bras J.
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [Abstract] [Full Text] [Related]

  • 11. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O, Muehlberger N, Jelinek T, Alifrangis M, Peyerl-Hoffmann G, Muhlen M, Grobusch MP, Gascon J, Matteelli A, Laferl H, Bisoffi Z, Ehrhardt S, Cuadros J, Hatz C, Gjorup I, McWhinney P, Beran J, da Cunha S, Schulze M, Kollaritsch H, Kern P, Fry G, Richter J, European Network on Surveillance of Imported Infectious Diseases.
    J Infect Dis; 2004 Nov 01; 190(9):1541-6. PubMed ID: 15478057
    [Abstract] [Full Text] [Related]

  • 12. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN, Kain KC.
    Expert Rev Anti Infect Ther; 2005 Dec 01; 3(6):849-61. PubMed ID: 16307498
    [Abstract] [Full Text] [Related]

  • 13. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD, Dragsted UB.
    Ugeskr Laeger; 2000 Jul 31; 162(31):4177-81. PubMed ID: 10962933
    [Abstract] [Full Text] [Related]

  • 14. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S, Gill MJ, Kain KC.
    Am J Trop Med Hyg; 2005 Apr 31; 72(4):407-9. PubMed ID: 15827276
    [Abstract] [Full Text] [Related]

  • 15. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK, Van Vugt M, Paiphun L, Slight T, Looareesuwan S, White NJ, Nosten F.
    Am J Trop Med Hyg; 2005 Aug 31; 73(2):267-8. PubMed ID: 16103586
    [Abstract] [Full Text] [Related]

  • 16. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
    Thapar MM, Gil JP, Björkman A.
    Trans R Soc Trop Med Hyg; 2005 Jan 31; 99(1):62-70. PubMed ID: 15550263
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.
    Am J Trop Med Hyg; 2007 Apr 31; 76(4):655-8. PubMed ID: 17426165
    [Abstract] [Full Text] [Related]

  • 18. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E, Bujanover S, Kain KC.
    Clin Infect Dis; 2003 Aug 01; 37(3):450-1. PubMed ID: 12884171
    [Abstract] [Full Text] [Related]

  • 19. Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs.
    McRobert L, Jiang S, Stead A, McConkey GA.
    Exp Parasitol; 2005 Nov 01; 111(3):178-81. PubMed ID: 16140296
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.